161 related articles for article (PubMed ID: 11906442)
21. Prophylactic mastectomy.
Newman LA; Kuerer HM; Hung KK; Vlastos G; Ames FC; Ross MI; Singletary SE
J Am Coll Surg; 2000 Sep; 191(3):322-30. PubMed ID: 10989906
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic mastectomy: is it worth it?
de la Peña-Salcedo JA; Soto-Miranda MA; Lopez-Salguero JF
Aesthetic Plast Surg; 2012 Feb; 36(1):140-8. PubMed ID: 21751064
[TBL] [Abstract][Full Text] [Related]
23. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.
Tercyak KP; Peshkin BN; Brogan BM; DeMarco T; Pennanen MF; Willey SC; Magnant CM; Rogers S; Isaacs C; Schwartz MD
J Clin Oncol; 2007 Jan; 25(3):285-91. PubMed ID: 17159191
[TBL] [Abstract][Full Text] [Related]
24. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
[TBL] [Abstract][Full Text] [Related]
25. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Seynaeve C; van Geel AN; Tilanus MM; Bartels CC; Verhoog LC; Brekelmans CT; Burger CW; Niermeijer MF
Breast Cancer Res Treat; 2002 May; 73(2):97-112. PubMed ID: 12088120
[TBL] [Abstract][Full Text] [Related]
26. Adjustment issues related to bilateral prophylactic mastectomy in women at elevated risk of developing breast cancer.
Fuller S; Anderson RC
Plast Surg Nurs; 2006; 26(2):60-5; quiz 66-7. PubMed ID: 16783176
[TBL] [Abstract][Full Text] [Related]
27. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
28. Mastectomy for risk reduction or symmetry in women without high risk gene mutation: A review.
Kenny R; Reed M; Subramanian A
Int J Surg; 2018 Feb; 50():60-64. PubMed ID: 29288115
[TBL] [Abstract][Full Text] [Related]
29. Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience.
Unukovych D; Sandelin K; Wickman M; Arver B; Johansson H; Brandberg Y; Liljegren A
Acta Oncol; 2012 Sep; 51(7):934-41. PubMed ID: 22409595
[TBL] [Abstract][Full Text] [Related]
30. Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer.
Meiser B; Butow P; Friedlander M; Schnieden V; Gattas M; Kirk J; Suthers G; Haan E; Tucker K
J Clin Oncol; 2000 Jun; 18(11):2250-7. PubMed ID: 10829045
[TBL] [Abstract][Full Text] [Related]
31. [Preventive surgical prcedures for inherited risk of breast cancer].
Menke-Pluymers MB; Seynaeve C; van Geel AN; Klijn JG; Meijers-Heijboer EJ; Eggermont AM
Ned Tijdschr Geneeskd; 2005 Nov; 149(48):2663-7. PubMed ID: 16358615
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic surgery for women at high risk for breast cancer.
Blanchard DK; Hartmann LC
Clin Breast Cancer; 2000 Jul; 1(2):127-34; discussion 135. PubMed ID: 11899651
[TBL] [Abstract][Full Text] [Related]
33. Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.
Angelos P; Bedrosian I; Euhus DM; Herrmann VM; Katz SJ; Pusic A
Ann Surg Oncol; 2015 Oct; 22(10):3208-12. PubMed ID: 26259752
[TBL] [Abstract][Full Text] [Related]
34. Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women.
Bresser PJ; Seynaeve C; Van Gool AR; Brekelmans CT; Meijers-Heijboer H; van Geel AN; Menke-Pluijmers MB; Duivenvoorden HJ; Klijn JG; Tibben A
Plast Reconstr Surg; 2006 May; 117(6):1675-82; discussion 1683-4. PubMed ID: 16651934
[TBL] [Abstract][Full Text] [Related]
35. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
36. Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: mental health and body image outcomes.
Hopwood P; Lee A; Shenton A; Baildam A; Brain A; Lalloo F; Evans G; Howell A
Psychooncology; 2000; 9(6):462-72. PubMed ID: 11180581
[TBL] [Abstract][Full Text] [Related]
37. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
[TBL] [Abstract][Full Text] [Related]
38. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
[TBL] [Abstract][Full Text] [Related]
39. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
40. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
Metcalfe KA; Esplen MJ; Goel V; Narod SA
Psychooncology; 2004 Jan; 13(1):14-25. PubMed ID: 14745742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
